A European provider in life science

Our vision is to improve people's lives by being a leading, value-adding partner in life science

Interim Report Q2 2023
Graph

Share price

2023-09-28

Calendar

  • AddLife Capital Markets Day

    On September 15 AddLife held a Capital Markets Day with the aim to offer insights into AddLife's business model, portfolio companies, and strategic plans. Our CEO Fredrik Dalborg and other key managers were presenting.

    Read more
    AddLife Capital Markets Day
  • Demand is developing positively in all areas

    AddLife's subsidiaries have strong market positions in growing niches, which is clearly reflected in the company's net sales growth of 14% in the second quarter. Operating profit (EBITA) increased by 3% compared with the previous year, driven primarily by higher net sales growth, and the EBITA margin was 10.4%. In summary, I can conclude that AddLife's companies have strong market positions in well-chosen niches where the conditions for continued profitable growth are good.

     

    CEO comments Q2
    Fredrik Dalborg Q2 2023 3 (1)

Our business areas

Medtech

MEDTECH

In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment for use in homecare. Medtech’s offering mainly focuses on public funded health care, homecare and social care in Europe.

Read more
Labtech

LABTECH

The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. Customers include hospitals, research laboratories, pharmaceutical companies, and food industry groups, primarily in the Nordics and rest of Europe.

Read more

Join the AddLife group

Do you have a life science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.

Acquisitions

News from our subsidiaries

Isfritt Fremhevet Bilde
22 August 2023
Hepro enters strategic cooperation with Norwegian IsFritt

IsFritt is a manufacturer of outdoor heating mats and a complete supplier of slip protection products for stairs and walkways that are developed for the Nordic climate. The products ensure that you have a safe surface and thus help prevent falls.

Hepro
15 August 2023 | Triolab OY
Technical support assisting customers

Triolab has its own technical support organisation consisting of 12 experienced professionals. Its purpose is to ensure the functionality of equipment used by our customers in human and veterinary health care and industrial and research fields, and to help if any problems occur.

08 August 2023 | Biolin Scientific
Biolin Scientific and DKSH extend strategic partnership in the APAC region

By appointing DKSH as its key partner in nine thriving markets across Asia-Pacific, Biolin Scientific ensures that cutting-edge surface science technologies and solutions are easily accessible to researchers and scientists in these regions.

31 July 2023 | AddLife
AddLife Capital Markets Day Invitation

AddLife invites investors, analysts, and financial media to it's hybrid Capital Markets Day on September 15, 2023.

See all news

Sustainability for AddLife

Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in life science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.

Adobestock 300716540